Opportunities Preloader

Please Wait.....

Report

South & Central America Colorectal Cancer Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality (Diagnosis Type, Therapy Type, and Imaging Type) and End User (Hospitals and Diagnostic & Research Laboratories)

Market Report I 2022-09-23 I 152 Pages I The Insight Partners
Discounted by 30% to 2024-06-30

The colorectal cancer market in South & Central America is expected to grow from US$ 681.70 million in 2022 to US$ 814.50 million by 2028; it is estimated to grow at a CAGR of 2.2% from 2022 to 2028.

The market for colorectal cancer in the region is expected to grow owing to rise in the incidences of colorectal cancer and increase in the demand for colonoscopy procedures in Brazil. The market is also attributed to grow in Argentina due to the rising advancement for the technology to prevent incidences of the cancers.

The Rest of South & Central America colorectal cancer market is segmented into Chile, Peru, Ecuador, and other countries. According to GLOBOCAN 2020 data, there were approximately 6,219 new colorectal cancer cases in Chile, representing 11.5% of all new cancer cases in both genders, and ~4,636 new colorectal cancer cases were diagnosed in all ages in Peru.

Moreover, the majority of the countries in Latin America lack adequate systematic screening or prevention programs. The general screening of people aged above 50 years is a cost-effective and efficacious way of reducing colorectal cancer. Several South & Central American countries have developed national guidelines for early detection, management, and follow-up of colorectal cancer. Further, Uruguay has implemented colorectal cancer screening programs, while Chile, Cuba, and Ecuador have initiated pilot studies.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South & Central America colorectal cancer market at a substantial CAGR during the forecast period.

South & Central America Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Colorectal Cancer Market Segmentation

The South & Central America colorectal cancer market is segmented into modality, and end user, and country. Based on modality, the global colorectal cancer market is segmented into diagnosis type, therapy type, and imaging type. In 2022, the diagnosis type segment holds the largest market share and is expected to register the highest CAGR during the forecast period. Based on end user, the global colorectal cancer market is bifurcated into hospitals and diagnostic & research laboratories. In 2022, the hospitals segment holds a larger market share. Based on country, the South & Central America colorectal cancer market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America held the largest market share in 2022.

Abbott, Amgen Inc., Bruker Corporation, Clinical Genomics Technologies Pty Ltd., EDP Biotech Corporation, Epigenomics AG, F. Hoffmann-La Roche AG, Quest Diagnostics, and VolitionRx Limited are among the leading companies operating in the South & Central America colorectal cancer market.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Colorectal Cancer Market - By Modality
1.3.2 SAM Colorectal Cancer Market - By End User
1.3.3 SAM Colorectal Cancer Market - By Country
2. SAM Colorectal Cancer Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Colorectal Cancer- Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
4.2.1 SAM Colorectal Cancer Market -PEST Analysis
4.3 Expert Opinion
5. SAM Colorectal Cancer Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Colorectal Cancer
5.1.2 New Product Launches
5.1.3 Benefits Offered by Generic Drugs
5.2 Market Restraints
5.2.1 Pricing Pressure on Drug Manufacturers
5.3 Future Trends
5.3.1 Inclination Toward Personalized Medicine
5.4 Impact Analysis
6. SAM Colorectal Cancer Market- SAM Analysis
6.1 SAM Colorectal Cancer Market Revenue Forecast and Analysis
6.1.1 Overview
7. SAM Colorectal Cancer Market Analysis - By Modality
7.1 Overview
7.2 SAM Colorectal Cancer Market Revenue Share, By Modality 2022 & 2028 (%)
7.3 Diagnosis Type
7.3.1 Overview
7.3.2 Diagnosis Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.3.3 Immunohistochemistry
7.3.3.1 Overview
7.3.3.2 Immunohistochemistry: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.3.4 Stool Test
7.3.4.1 Overview
7.3.4.2 Stool Test : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.3.5 Flexible Sigmoidoscopy
7.3.5.1 Overview
7.3.5.2 Flexible Sigmoidoscopy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.3.6 Colonoscopy
7.3.6.1 Overview
7.3.6.2 Colonoscopy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.3.7 CEA Test
7.3.7.1 Overview
7.3.7.2 CEA Test: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.3.8 Other Test
7.3.8.1 Overview
7.3.8.2 Other Test: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Therapy Type
7.4.1 Overview
7.4.2 SAM Therapy Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.3 Chemotherapy
7.4.3.1 Overview
7.4.3.2 Chemotherapy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.3.3 Alkylating Agent
7.4.3.3.1 Overview
7.4.3.3.2 Alkylating Agent: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.3.4 Antimetabolites
7.4.3.4.1 Antimetabolites: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.3.5 Others
7.4.3.5.1 Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.4 Immunotherapy
7.4.4.1 Overview
7.4.4.2 Immunotherapy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.4.3 Panitumumab
7.4.4.3.1 Overview
7.4.4.3.2 Panitumumab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.4.4 Cetuximab
7.4.4.4.1 Overview
7.4.4.4.2 Cetuximab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.4.5 Bevacizumab
7.4.4.5.1 Overview
7.4.4.5.2 Bevacizumab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.4.6 Others
7.4.4.6.1 Overview
7.4.4.6.2 Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.5 Chemoprotectant
7.4.5.1 Overview
7.4.5.2 Chemoprotectant: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.6 Others
7.4.6.1 Overview
7.4.6.2 Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Imaging Type
7.5.1 Overview
7.5.2 SAM Imaging Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.5.3 Computed Tomography (CT)
7.5.3.1 Overview
7.5.3.2 Computed Tomography (CT): Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.5.4 Magnetic Resonance Imaging (MRI)
7.5.4.1 Overview
7.5.4.2 Magnetic Resonance Imaging (MRI): Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.5.5 Others
7.5.5.1 Overview
7.5.5.2 Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
8. SAM Colorectal Cancer Market Revenue and Forecast To 2028 - By End User
8.1 Overview
8.2 SAM Colorectal Cancer Market Revenue Share, By End User 2022 & 2028 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostic and Research Laboratories
8.4.1 Overview
8.4.2 Diagnostic and Research Laboratories: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9. SAM Colorectal Cancer Market Revenue and Forecast to 2028 - Country Analysis
9.1 Overview
9.1.1 SAM: Colorectal Cancer Market Share, by Country (2022 & 2028) (%)
9.1.1.1 Brazil: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.1 Brazil: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.2 Brazil: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.1.2.1 Brazil: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
9.1.1.1.2.2 Brazil: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
9.1.1.1.2.2.1 Brazil: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
9.1.1.1.2.2.2 Brazil: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
9.1.1.1.2.3 Brazil: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
9.1.1.1.3 Brazil: Colorectal Cancer Market - Revenue and Forecast to 2028, By End Users (US$ Million)
9.1.1.2 Argentina: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.1 Argentina: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.2 Argentina: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.2.2.1 Argentina: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
9.1.1.2.2.2 Argentina: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
9.1.1.2.2.2.1 Argentina: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
9.1.1.2.2.2.2 Argentina: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
9.1.1.2.2.3 Argentina: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
9.1.1.2.3 Argentina: Colorectal Cancer Market - Revenue and Forecast to 2028, By End Users (US$ Million)
9.1.1.3 Rest of SAM: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.1 Rest of SAM: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.2 Rest of SAM: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.3.2.1 Rest of SAM: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
9.1.1.3.2.2 Rest of SAM: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
9.1.1.3.2.2.1 Rest of SAM: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
9.1.1.3.2.2.2 Rest of SAM: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
9.1.1.3.2.3 Rest of SAM: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
9.1.1.3.3 Rest of SAM: Colorectal Cancer Market - Revenue and Forecast to 2028, By End Users (US$ Million)
10. Colorectal Cancer Market - Industry Landscape
10.1 Overview
10.2 Growth Strategies In The Colorectal Cancer Market, 2022-2028
10.3 Organic Developments
10.3.1 Overview
10.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2022-2028
10.4 Inorganic Developments
10.4.1 Overview
10.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2022-2028
11. Company Profiles
11.1 Epigenomics AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Abbott
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Amgen Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 F. HOFFMANN-LA ROCHE LTD.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Bruker Corporation
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Quest Diagnostics Incorporated
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Volitionrx Limited
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms

LIST OF TABLES

Table 1. SAM Colorectal Cancer Market Share, by Country (2022 & 2028) (%)
Table 2. Brazil: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
Table 3. Brazil: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
Table 4. Brazil: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
Table 5. Brazil: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 6. Brazil: Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 7. Brazil: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
Table 8. Brazil: Colorectal Cancer Market - Revenue and Forecast to 2028, By End User (US$ Million)
Table 9. Argentina: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
Table 10. Argentina: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
Table 11. Argentina: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
Table 12. Argentina: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 13. Argentina: Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 14. Argentina: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
Table 15. Argentina: Colorectal Cancer Market - Revenue and Forecast to 2028, By End Users (US$ Million)
Table 16. Rest of SAM: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
Table 17. Rest of SAM: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of SAM: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of SAM: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 20. Rest of SAM: Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of SAM: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of SAM: Colorectal Cancer Market - Revenue and Forecast to 2028, By End Users (US$ Million)
Table 23. Recent Organic Growth Strategies In The Colorectal Cancer Market
Table 24. Recent Inorganic Growth Strategies In The Colorectal Cancer Market
Table 25. Glossary of Terms, SAM Colorectal Cancer Market



LIST OF FIGURES

Figure 1. SAM Colorectal Cancer Market Segmentation
Figure 2. SAM Colorectal Cancer Segmentation, By Country
Figure 3. SAM Colorectal Cancer Market Overview
Figure 4. Diagnosis Type Segment Held Largest Share Of Modality Segment In SAM Colorectal Cancer Market
Figure 5. Brazil is Expected To Show Remarkable Growth During The Forecast Period
Figure 6. Comparison of Branded Drugs and Generic Drugs
Figure 7. MEA Colorectal Cancer Market Impact Analysis of Drivers And Restraints
Figure 8. SAM Colorectal Cancer Market - Revenue Forecasts And Analysis - 2019- 2028
Figure 9. SAM Colorectal Cancer Market Revenue Share, by Modality 2022 & 2028 (%)
Figure 10. SAM Diagnosis Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 11. SAM Immunohistochemistry: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. SAM Stool Test: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. SAM Flexible Sigmoidoscopy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. SAM Colonoscopy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. SAM CEA Test: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. SAM Other Test: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. SAM Therapy Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. SAM Chemotherapy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Alkylating Agent: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. SAM Antimetabolites: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. SAM Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. SAM Immunotherapy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. SAM Panitumumab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. SAM Cetuximab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. SAM Bevacizumab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. SAM Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. SAM Chemoprotectant: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. SAM Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. SAM Imaging Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Computed Tomography (CT): Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. SAM Magnetic Resonance Imaging (MRI): Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. SAM Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. SAM Colorectal Cancer Market Revenue Share, by End User 2022 & 2028 (%)
Figure 34. SAM Hospitals: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. SAM Diagnostic and Research Laboratories: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. SAM Colorectal Cancer Market Overview, by Country (2022)
Figure 37. Brazil: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 38. Argentina: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 39. Rest of SAM: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. Growth Strategies In The Colorectal Cancer Market, 2022-2028

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $3000.00 $2100.00
  • $4000.00 $2800.00
  • $5000.00 $3500.00
  • ADD TO BASKET
  • BUY NOW